Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Appendix A
Terms and Abbreviations Used In This Report
ABMG American Board of Medical Genetics
ABN Advance beneficiary notice
Accuracy Closeness of the agreement between the result of a measurement and a true value of the measurand
ACMG American College of Medical Genetics
Allele One version of a gene at a given location (locus) along a chromosome
AMP Association for Molecular Pathology
Amplicon Piece of nucleic acid formed as the product of molecular amplification
Amplification In vitro enzymatic replication of a target nucleic acid (e.g., polymerase chain reaction [PCR])
ASR Analyte-specific reagent
Bidirectional sequencing A method used to determine the positions of a selected nucleotide base in a target region on both strands of a denatured duplex nucleic acid polymer
CAP College of American Pathologists
CDC Centers for Disease Control and Prevention
CLIA Clinical Laboratory Improvement Amendments of 1988
CLIAC Clinical Laboratory Improvement Advisory Committee
CLSI Clinical and Laboratory Standards Institute (formerly NCCLS)
CMS Centers for Medicare & Medicaid Services
Competency assessment Evaluation of a person's ability to perform all aspects of testing, from specimen collection to result reporting
Control material A device, material, solution, or lyophilized preparation intended for use in the quality-control process
CPT Current Procedural Terminology
CVS Chorionic villus sampling
DNA Deoxyribonucleic acid, the molecule that encodes genetic information
DTC Direct to consumer
Family history The genetic relationships and medical history of a family; also referred to as a pedigree when represented in diagram form using standardized symbols and terminology
FDA Food and Drug Administration
Founder effect The presence of gene mutation in high frequency in a specific population that arises because the gene mutation was present in a single ancestor or small number of ancestors in the founding population
Genetics The study of inheritance patterns of specific traits
Genome The complete genetic content of an organism
Genotype The genetic constitution of an organism or cell; also refers to the specific set of alleles inherited at a locus
Germline mutation The presence of an altered gene within the egg or sperm (germ cell), such that the altered gene can be passed to subsequent generations
Heterozygote A person with two different alleles at a particular locus, one on each chromosome of a pair, typically with one normal and one abnormal allele
HHS Department of Health and Human Services
HIPAA Health Insurance Portability and Accountability Act of 1996
Homozygote Person with two identical alleles at a particular locus, one on each chromosome of a pair
ICD International Classification of Disease
Informed consent process For molecular genetic testing, the process by which a person voluntarily confirms the willingness to participate in a particular test, after having been informed of all aspects of the test that are relevant to the decision to participate
LOD Lower limit of detection
Modifiers Genetic or environmental factors that might affect the expressivity (the variability of signs or symptoms that occur with a phenotype) of a genetic alteration
Mutation An alteration in a gene, which might cause a disease, be a benign alteration, or result in a normal variant
Newborn screening Testing conducted within days of birth to identify infants at increased risk for specific genetic disorders, allowing education and counseling for parents and treatment for patients to be initiated as soon as possible
NTC No-template control
Pedigree A diagram using standard symbols and terminology to indicate the genetic relationships and medical history of a family
Penetrance The proportion of persons with a mutation causing a particular disorder who exhibit clinical symptoms of the disorder
Personalized medicine Approach to medicine involving use of genomic and molecular data to better target health care, facilitate discovery and clinical testing of new products, and determine patient risk for a particular disease or condition
Phenotype The observable physical and biochemical traits resulting from of the expression of a gene; the clinical presentation of a person with a particular genotype
Polymerase chain reaction (PCR) A DNA amplification procedure that produces millions of copies of a short segment of DNA through repeated cycles of 1) denaturation, 2) annealing, and 3) elongation; a very common procedure in molecular genetic testing used to generate a sufficient quantity of DNA to perform a test (e.g., sequence analysis or mutation scanning) or as a test itself (e.g., allele-specific amplification or trinucleotide repeat quantification)
Positive predictive value The likelihood that a person with a positive test result actually has a particular gene, is affected by the gene, or will develop the disease
Precision Closeness of agreement between independent test results obtained under stipulated conditions
Private mutation A rare, disease-causing mutation occurring in a few families
Proficiency testing An external quality assessment program in which samples are periodically sent to testing sites for analysis
Quality assessment A group of activities to monitor and evaluate the entire testing process; used to help ensure that test results are reliable, improve the testing process, and promote good quality testing practices
Quality control Measures taken to detect, reduce, and correct deficiencies in a laboratory's internal analytical process prior to the release of patient results and to improve the quality of the results reported by the laboratory
Reagent A substance that produces a chemical or biological reaction with a patient specimen, allowing detection or measurement of the analyte for which the test is designed
Reference interval Interval between and including the lower reference limit through the upper reference limit of the reference population (e.g., 95% of persons presumed to be healthy [or normal])
Reportable range The range of test values over which the relationship between the instrument, kit, or measurement response of the system is shown to be valid
RNA Ribonucleic acid
SACGHS Secretary's Advisory Committee on Genetics, Health, and Society
Sequencing A procedure used to determine the order of nucleotides (base sequence) in a DNA or RNA molecule or the order of amino acids in a protein
Targeted mutation analysis Testing for one or more specific mutations
Total testing process Series of activities or workflow for performing testing; includes three major phases: preanalytic, analytic, and postanalytic
Unidirectional workflow The manner in which testing personnel and patient specimens move through the molecular amplification testing process to prevent cross-contamination
Variant Any heritable change in DNA sequence
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services. |
All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 5/29/2009